Mesenchymal stromal cells coated with anti-ACE2 antibodies might improve efficacy against COVID-19

Hum Cell. 2022 Jan;35(1):418-420. doi: 10.1007/s13577-021-00620-1. Epub 2021 Sep 30.

Nourhan Saied Bakry^#¹, Mai Abdelgawad^#¹, Ahmed Abdel-Latif^{2

3}, Ahmed Lotfy⁴

¹ Biotechnology and Life Sciences Department, Faculty of Postgraduate Studies for Advanced Sciences (PSAS), Beni-Suef University, Beni-Suef, 62511, Egypt.
² Gill Heart Institute and Division of Cardiovascular Medicine, University of Kentucky and the Lexington VA Medical Center, Lexington, KY, USA. abdel-latif@uky.edu.
³ College of Medicine, University of Kentucky, Lexington, KY, 40506-0046, USA. abdel-latif@uky.edu.
⁴ Biotechnology and Life Sciences Department, Faculty of Postgraduate Studies for Advanced Sciences (PSAS), Beni-Suef University, Beni-Suef, 62511, Egypt. ahmed.lotfy@psas.bsu.edu.eg.

^# Contributed equally.

No abstract available

Publication types